Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chemokine CCL8 | 2 | 2014 | 17 | 0.490 |
Why?
|
| Th2 Cells | 4 | 2016 | 1079 | 0.480 |
Why?
|
| Chemokines, CC | 2 | 2022 | 286 | 0.450 |
Why?
|
| Receptors, CCR8 | 1 | 2013 | 28 | 0.440 |
Why?
|
| Immunity, Innate | 1 | 2023 | 3078 | 0.380 |
Why?
|
| Chemokine CCL1 | 1 | 2011 | 22 | 0.370 |
Why?
|
| Receptors, Leukotriene B4 | 3 | 2005 | 93 | 0.360 |
Why?
|
| Cytokines | 2 | 2023 | 7445 | 0.320 |
Why?
|
| Epithelium | 1 | 2012 | 1609 | 0.290 |
Why?
|
| Hypersensitivity | 2 | 2016 | 1173 | 0.280 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2003 | 808 | 0.230 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 152 | 0.230 |
Why?
|
| HLA-DR Antigens | 1 | 2005 | 607 | 0.220 |
Why?
|
| Chemokines | 2 | 2022 | 962 | 0.220 |
Why?
|
| Dermatitis, Atopic | 1 | 2011 | 733 | 0.210 |
Why?
|
| T-Lymphocytes | 3 | 2014 | 10267 | 0.200 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2005 | 617 | 0.190 |
Why?
|
| Interleukin-13 | 1 | 2023 | 391 | 0.190 |
Why?
|
| Cell Movement | 3 | 2023 | 5215 | 0.170 |
Why?
|
| Chemotaxis | 2 | 2013 | 600 | 0.160 |
Why?
|
| Skin | 2 | 2022 | 4499 | 0.160 |
Why?
|
| Asthma | 4 | 2016 | 6280 | 0.140 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2001 | 1795 | 0.140 |
Why?
|
| Allergens | 2 | 2016 | 1441 | 0.140 |
Why?
|
| Skin Transplantation | 1 | 2022 | 1097 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2023 | 2611 | 0.130 |
Why?
|
| Leukotriene B4 | 2 | 2005 | 281 | 0.110 |
Why?
|
| Listeriosis | 1 | 2014 | 147 | 0.100 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2013 | 381 | 0.100 |
Why?
|
| Listeria monocytogenes | 1 | 2014 | 246 | 0.100 |
Why?
|
| Mice | 8 | 2023 | 82017 | 0.090 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2011 | 141 | 0.090 |
Why?
|
| Adoptive Transfer | 2 | 2011 | 824 | 0.090 |
Why?
|
| Interleukin-5 | 1 | 2011 | 267 | 0.090 |
Why?
|
| Inflammation | 4 | 2016 | 10863 | 0.080 |
Why?
|
| HIV-1 | 3 | 2001 | 6963 | 0.080 |
Why?
|
| Eosinophils | 1 | 2013 | 953 | 0.080 |
Why?
|
| Ligands | 2 | 2013 | 3283 | 0.080 |
Why?
|
| Cloning, Molecular | 2 | 2011 | 4168 | 0.070 |
Why?
|
| Lung | 2 | 2023 | 10089 | 0.070 |
Why?
|
| Calcium Signaling | 1 | 2011 | 739 | 0.070 |
Why?
|
| Animals | 9 | 2023 | 169337 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2005 | 761 | 0.060 |
Why?
|
| Toxoplasmosis | 1 | 2006 | 94 | 0.060 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2005 | 47 | 0.060 |
Why?
|
| Phylogeny | 1 | 2013 | 2843 | 0.060 |
Why?
|
| Transfection | 1 | 2013 | 5764 | 0.060 |
Why?
|
| Receptors, CCR6 | 1 | 2005 | 73 | 0.060 |
Why?
|
| Immunologic Memory | 1 | 2012 | 1374 | 0.060 |
Why?
|
| Receptors, CCR2 | 1 | 2005 | 216 | 0.060 |
Why?
|
| Interferon-gamma | 4 | 2006 | 3164 | 0.060 |
Why?
|
| Food Hypersensitivity | 1 | 2012 | 733 | 0.060 |
Why?
|
| Receptors, CCR5 | 1 | 2006 | 491 | 0.060 |
Why?
|
| Mice, Knockout | 5 | 2014 | 14481 | 0.060 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2005 | 220 | 0.050 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2003 | 94 | 0.050 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2003 | 70 | 0.050 |
Why?
|
| Pseudogenes | 1 | 2003 | 104 | 0.050 |
Why?
|
| Pan troglodytes | 1 | 2003 | 224 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2011 | 19022 | 0.050 |
Why?
|
| Herpesvirus 4, Human | 2 | 2005 | 1082 | 0.050 |
Why?
|
| Cell Line | 3 | 2013 | 15597 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 652 | 0.050 |
Why?
|
| HIV Infections | 4 | 2002 | 17575 | 0.050 |
Why?
|
| Gene Products, vpr | 1 | 2001 | 33 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2005 | 1157 | 0.050 |
Why?
|
| Orthomyxoviridae | 1 | 2002 | 148 | 0.050 |
Why?
|
| Protein Binding | 1 | 2013 | 9343 | 0.050 |
Why?
|
| Gene Expression | 1 | 2013 | 7598 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2003 | 1813 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2003 | 4411 | 0.040 |
Why?
|
| Calcium | 1 | 2013 | 5794 | 0.040 |
Why?
|
| Macrophages | 1 | 2014 | 5796 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 2750 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 4 | 2011 | 22355 | 0.040 |
Why?
|
| Clone Cells | 1 | 2001 | 1671 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2005 | 5496 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2006 | 2206 | 0.030 |
Why?
|
| Zalcitabine | 1 | 1996 | 43 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 11918 | 0.030 |
Why?
|
| Lung Transplantation | 1 | 2005 | 1309 | 0.030 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1996 | 223 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2002 | 1802 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2011 | 18362 | 0.030 |
Why?
|
| Acute Disease | 1 | 2005 | 7242 | 0.030 |
Why?
|
| Mucus | 1 | 2016 | 346 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2005 | 4646 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 12166 | 0.030 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1996 | 622 | 0.030 |
Why?
|
| Humans | 13 | 2022 | 768393 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 930 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2005 | 4505 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2014 | 354 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2005 | 22296 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2002 | 9379 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2022 | 4209 | 0.020 |
Why?
|
| Proteomics | 1 | 2002 | 3906 | 0.020 |
Why?
|
| Molecular Sequence Data | 4 | 2003 | 17626 | 0.020 |
Why?
|
| Base Sequence | 3 | 2005 | 12422 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 13423 | 0.020 |
Why?
|
| Hybridization, Genetic | 1 | 2006 | 102 | 0.020 |
Why?
|
| Survival | 1 | 2006 | 160 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 228 | 0.020 |
Why?
|
| Toxoplasma | 1 | 2006 | 159 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2001 | 14784 | 0.010 |
Why?
|
| Phenotype | 2 | 2016 | 16721 | 0.010 |
Why?
|
| Disease Progression | 1 | 2001 | 13646 | 0.010 |
Why?
|
| Time Factors | 2 | 2006 | 40272 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2006 | 577 | 0.010 |
Why?
|
| Hepatitis, Viral, Animal | 1 | 2003 | 10 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 1769 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2005 | 677 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1996 | 3064 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 2003 | 5900 | 0.010 |
Why?
|
| Complementarity Determining Regions | 1 | 2002 | 150 | 0.010 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 36 | 0.010 |
Why?
|
| Gene Products, vif | 1 | 2001 | 31 | 0.010 |
Why?
|
| Immunodominant Epitopes | 1 | 2002 | 244 | 0.010 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 51 | 0.010 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2001 | 55 | 0.010 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2001 | 150 | 0.010 |
Why?
|
| Neutrophils | 1 | 2014 | 3785 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2003 | 660 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7599 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 1794 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2003 | 827 | 0.010 |
Why?
|
| Trachea | 1 | 2005 | 1095 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 2176 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2003 | 1506 | 0.010 |
Why?
|
| Collagen | 1 | 2005 | 2646 | 0.010 |
Why?
|
| Saquinavir | 1 | 1996 | 29 | 0.010 |
Why?
|
| Deoxyribonucleotides | 1 | 1996 | 43 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 6234 | 0.010 |
Why?
|
| Hepacivirus | 1 | 2003 | 1342 | 0.010 |
Why?
|
| Base Composition | 1 | 1996 | 291 | 0.010 |
Why?
|
| HIV Reverse Transcriptase | 1 | 1996 | 214 | 0.010 |
Why?
|
| Epitopes | 1 | 2001 | 2525 | 0.010 |
Why?
|
| Lamivudine | 1 | 1996 | 367 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1996 | 354 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1996 | 739 | 0.010 |
Why?
|
| HIV Protease Inhibitors | 1 | 1996 | 432 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1996 | 830 | 0.010 |
Why?
|
| Hepatitis C | 1 | 2003 | 1593 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 9562 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 4570 | 0.010 |
Why?
|
| Quinolines | 1 | 1996 | 768 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 1996 | 1341 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 2001 | 5151 | 0.000 |
Why?
|
| Virus Replication | 1 | 1996 | 2458 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2002 | 12805 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 20224 | 0.000 |
Why?
|
| Adult | 1 | 2016 | 223640 | 0.000 |
Why?
|
| Mutation | 1 | 1996 | 30228 | 0.000 |
Why?
|
| Male | 1 | 2003 | 364902 | 0.000 |
Why?
|
| Female | 1 | 2003 | 397089 | 0.000 |
Why?
|
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_